Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Godfrey Phillips India Limited (GODFRYPHLP.NS)
New Delhi, IN
Established in 1936 and headquartered in New Delhi, India, Godfrey Phillips India Limited (GPI) is a key enterprise primarily engaged in the production and distribution of cigarettes, chewing tobacco, and other tobacco-based items across India. The company's business activities are structured around several core divisions: Cigarette, Tobacco, and Related Products; Retail and Associated Products; and an "Others" segment. GPI's operations also extend to manufacturing cut tobacco and playing a significant role in the trading and supply of various tobacco products, general retail goods, and vaping devices. Its diverse portfolio includes well-known cigarette brands such as Four Square, Red and White, Cavanders, Stellar, North Pole, Tipper, and Marlboro. Beyond tobacco, Godfrey Phillips India offers pan masala under the Pan Vilas and RAAG labels, the Pan Vilas Silver Dewz mouth freshener, and Funda Goli candies. Further diversifying its presence, the company manages a chain of convenience stores operating under the 24SEVEN brand and holds interests in the real estate sector. Additionally, Godfrey Phillips India actively exports its wide range of products to international markets.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.00% | +0.00% | +9.84% | +17.38% | -17.36% | -12.21% | -13.37% | +319.52% | +724.80% | +710.68% | +9,785.45% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2026-04 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Tobacco: +5.3%+13.9% ★ Q1'26: +13.6% (vs Q1'25)
-
EPS growth Tobacco: +18.8%+32.0% ★ Q1'26: +77.1% (vs Q1'25)
-
FCF margin FCF growth · Tobacco: +9.5%+4.2% Q1'26: +23.2% (vs Q1'25)
-
EBIT margin Tobacco: +20.5%+22.9% ★ Q1'26: +29.1% (vs Q1'25)
-
ROIC Tobacco: +16.0%+19.7% ★ Q1'26: +27.7% (vs Q1'25)
-
Share dilution Tobacco: +0.0%+0.3% Q1'26: +0.3% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Tobacco: 0.25×0.15× ★ Q1'26: 0.11× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Mar 1996 actual |
Mar 1997 actual |
Mar 1998 actual |
Mar 2000 actual |
Mar 2001 actual |
Mar 2015 actual |
Mar 2016 actual |
Mar 2017 actual |
Mar 2018 actual |
Mar 2020 actual |
Mar 2021 actual |
Mar 2022 actual |
Mar 2023 actual |
Mar 2024 actual |
Mar 2025 actual |
Mar 2026 1 Rev. Ana. 1 EPS Ana. |
Mar 2027 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
7.96B
est.
|
8.44B
est.
|
5.33B
est.
|
5.34B
est.
|
5.87B
est.
|
25.87B
est: 28.67B (-9.8%)
|
23.31B
est: 32.83B (-29.0%)
|
24.03B
est: 28.67B (-16.2%)
|
23.26B
est: 32.83B (-29.2%)
|
28.77B
est: 30.07B (-4.4%)
|
25.25B
est: 26.89B (-6.1%)
|
26.88B
est: 26.88B (0.0%)
|
35.62B
est: 40.36B (-11.7%)
|
40.18B
est: 45.48B (-11.6%)
|
56.11B
est: 50.77B (+10.5%)
|
58.00B
58.00B – 58.00B
+14.2% YoY
|
65.14B
65.14B – 65.14B
+12.3% YoY
|
| EBITDA |
1.68B
est.
|
1.74B
est.
|
1.10B
est.
|
1.10B
est.
|
1.21B
est.
|
3.70B
est: 6.04B (-38.7%)
|
3.31B
est: 6.92B (-52.1%)
|
2.57B
est: 6.04B (-57.5%)
|
2.63B
est: 6.92B (-62.0%)
|
5.51B
est: 3.90B (+41.3%)
|
4.93B
est: 6.26B (-21.2%)
|
5.82B
est: 6.94B (-16.1%)
|
7.62B
est: 7.15B (+6.6%)
|
8.91B
est: 9.58B (-7.1%)
|
11.58B
est: 13.94B (-16.9%)
|
15.92B
15.92B – 15.92B
+14.2% YoY
|
17.88B
17.88B – 17.88B
+12.3% YoY
|
| EBIT |
1.47B
est.
|
1.52B
est.
|
962.57M
est.
|
964.14M
est.
|
1.06B
est.
|
2.62B
est: 5.28B (-50.4%)
|
2.26B
est: 6.05B (-62.6%)
|
1.61B
est: 5.28B (-69.6%)
|
1.67B
est: 6.05B (-72.4%)
|
4.48B
est: 2.94B (+52.3%)
|
4.05B
est: 4.30B (-5.8%)
|
4.93B
est: 4.77B (+3.3%)
|
6.68B
est: 4.92B (+35.8%)
|
7.99B
est: 6.82B (+17.3%)
|
10.72B
est: 13.89B (-22.8%)
|
15.86B
15.86B – 15.86B
+14.2% YoY
|
17.82B
17.82B – 17.82B
+12.3% YoY
|
| Net Income |
291.86M
est.
|
580.86M
est.
|
767.12M
est.
|
1.72B
est.
|
1.86B
est.
|
1.83B
est: 8.65B (-78.8%)
|
1.70B
est: 10.22B (-83.4%)
|
1.37B
est: 8.65B (-84.1%)
|
1.59B
est: 3.41B (-53.3%)
|
3.85B
est: 2.35B (+63.5%)
|
3.77B
est: 3.77B (-0.1%)
|
4.38B
est: 4.18B (+4.8%)
|
6.90B
est: 4.31B (+60.3%)
|
8.83B
est: 8.98B (-1.7%)
|
10.72B
est: 11.45B (-6.4%)
|
14.52B
14.52B – 14.52B
+26.8% YoY
|
17.48B
17.48B – 17.48B
+20.5% YoY
|
| SGA |
956.91M
est.
|
994.39M
est.
|
627.80M
est.
|
628.83M
est.
|
2.53B
est.
|
6.18B
est: 3.45B (+79.2%)
|
4.53B
est: 3.95B (+14.9%)
|
4.24B
est: 3.45B (+23.1%)
|
4.03B
est: 3.95B (+2.1%)
|
4.38B
est: 12.90B (-66.0%)
|
3.38B
est: 8.83B (-61.8%)
|
3.54B
est: 9.79B (-63.9%)
|
4.01B
est: 10.09B (-60.3%)
|
4.65B
est: 5.47B (-14.9%)
|
6.03B
est: 6.03B (0.0%)
|
6.89B
6.89B – 6.89B
+14.2% YoY
|
7.74B
7.74B – 7.74B
+12.3% YoY
|
| EPS |
1.88
est.
|
3.75
est.
|
4.96
est.
|
11.14
est.
|
12.04
est.
|
11.75
est: 55.63 (-78.9%)
|
10.88
est: 65.73 (-83.4%)
|
8.80
est: 55.63 (-84.2%)
|
10.20
est: 21.91 (-53.4%)
|
24.67
est: 27.34 (-9.8%)
|
24.14
est: 22.30 (+8.3%)
|
28.08
est: 28.40 (-1.1%)
|
44.27
est: 44.69 (-0.9%)
|
59.34
est: 57.77 (+2.7%)
|
74.12
est: 73.40 (+1.0%)
|
93.07
93.07 – 93.07
+26.8% YoY
|
112.10
112.10 – 112.10
+20.5% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-15 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-14 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-13 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-12 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-11 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-08 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-07 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-06 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-05 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-04 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-30 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-29 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-28 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-27 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-24 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-23 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-22 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-21 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-20 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-17 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-16 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-15 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Bina Modi | Chairperson of the Board, Chief Executive Officer & MD | 451M | — |
| Charu Modi | Executive Director | 430M | female |
| Sharad Aggarwal | Functional Chief Executive Officer & Whole-Time Director | 372M | male |
| Lokesh Singh | Vice President and Head of Sales & Distribution | — | male |
| Pumit Kumar Chellaramani | Compliance Officer & Company Secretary | — | male |
| Sakshi Anand | SVP, CHRO & Head of ESG | — | female |
| Siddharth Chawla | Chief Operating Officer & Chief Risk Officer | — | male |
| Sunil Agrawal | Executive Vice President | — | male |
| Vishal Dhariwal | Chief Financial Officer | — | male |
| Jaishree Tolani | General Counsel | — | female |
| Kusumakar Pandey | Senior VP & Head IBD & SIA | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for GODFRYPHLP.NS
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
